Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcabene in Severe Hypertriglyceridemia (INDIGO-1)
NCT02944383Phase 2Completed
- Sponsor
- NeuroBo Pharmaceuticals
- Start
- Dec 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of gemcabene in hypertriglyceridemia (3 arms), sponsored by NeuroBo Pharmaceuticals. Primary endpoint: Percent Change From Baseline to End of Study in Fasting Serum Triglycerides at 12 weeks. Started Dec 2016; status: completed.
02
Drugs
gemcabene
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT02944383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02944383.